Astellas Pharma

Astellas Pharma Current Liabilities

The Current Liabilities of Astellas Pharma (4503.T) as of Nov 5, 2026 is 1.22 T JPY. In the previous year, Current Liabilities was 1.16 T JPY — a change of 5.07% (higher).

Current Liabilities

1.22 TJPY

YoY

5.07%

Last updated:

Current Liabilities of Astellas Pharma is 2026 1.22 T JPY. Current Liabilities of Astellas Pharma was 2025 1.16 T JPY. It decreases by 5.07% higher compared to the previous year.

The Astellas Pharma Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
484.78 B JPY
Jan 1, 2020
805.12 B JPY
Jan 1, 2021
600.08 B JPY
Jan 1, 2022
809.31 B JPY
Jan 1, 2023
878.26 B JPY
Jan 1, 2024
1.31 T JPY
Jan 1, 2025
1.16 T JPY
Jan 1, 2026
1.22 T JPY
The Astellas Pharma Current Liabilities history
YEARCurrent LiabilitiesYoY
1.22 TJPY+5.07%
1.16 TJPY-11.75%
1.31 TJPY+49.62%
878.26 BJPY+8.52%
809.31 BJPY+34.87%
600.08 BJPY-25.47%
805.12 BJPY+66.08%
484.78 BJPY+43.91%
336.85 BJPY+1.90%
330.56 BJPY-9.87%
366.77 BJPY-10.13%
408.11 BJPY+24.23%
328.51 BJPY-21.66%
419.36 BJPY+13.21%
370.42 BJPY+26.44%
292.96 BJPY-7.96%
318.29 BJPY+7.48%
296.15 BJPY-13.68%
343.06 BJPY-8.92%
376.67 BJPY+6.96%
352.15 BJPY+147.44%
142.32 BJPY+6.24%
133.96 BJPY-22.91%
173.76 BJPY-2.65%
178.48 BJPY+17.57%
151.80 BJPY+11.44%
136.22 BJPY+2.81%
132.49 BJPY-13.63%
153.40 BJPY-11.47%
173.26 BJPY+51.14%
114.64 BJPY-16.45%
137.21 BJPY+29.88%
105.64 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Astellas Pharma Stock analysis

What does Astellas Pharma do? Astellas Pharma Inc. is a global pharmaceutical company based in Tokyo, Japan. The company manufactures and distributes medications worldwide. It was formed in April 2005 through the merger of two well-known Japanese pharmaceutical companies - Yamanouchi and Fujisawa. This merger created one of Japan's largest pharmaceutical companies and allowed for collaboration on the global market and the development of new innovations in medication research. Astellas' business model is focused on targeted research and development, comprehensive marketing and distribution networks, and collaboration with international partners. The company's main areas of focus are cancer, urology, transplantation, anti-infectives, and pneumology. Astellas has expanded its business through acquisitions and partnerships and currently operates in over 50 countries worldwide. In addition to pharmaceutical production, the company also provides services and consulting in the medical and health sectors. Astellas' business is divided into segments including pharmaceuticals, medical devices, and diagnostics. The pharmaceutical segment is the largest and offers a wide range of prescription medications for various medical areas. The medical devices segment specializes in the development and manufacturing of medical devices such as catheters, stents, and heart valves. The diagnostics segment focuses on developing and producing testing systems and instruments for diseases such as HIV and infectious diseases. Overall, Astellas is an important player in the global pharmaceutical and health industry, known for its innovative research, wide range of products, and collaboration with partners to develop campaigns against various diseases. Astellas Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Astellas Pharma stock

Current Liabilities of Astellas Pharma is 1.22 T JPY in 2026.

Current Liabilities of Astellas Pharma changed from 1.16 T JPY to 1.22 T JPY, representing a 5.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Astellas Pharma since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Astellas Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Astellas Pharma

All Key Metrics — Astellas Pharma